Repligen | RGEN - 股票

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 7.32B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	股票	更改		日
Agilent	USD 1.06B		34M	2025-12
Align Technology	USD 228.16M		15.59M	2025-09
Bio Techne	USD 205.45M		2.26M	2025-12
BioMarin Pharmaceutical	USD 1.3B		83.29M	2025-12
Bristol-Myers Squibb	USD 2.76B		21M	2025-09
Bruker	USD 1.2B		21.7M	2025-09
Charles River Laboratories	USD 299.1M		3.45M	2025-12
Danaher	USD 2.61B		119M	2026-03
Dentsply International	USD 642M		44M	2025-12
General Electric Aerospace	USD 12.37B		499M	2026-03
Henry Schein	USD 2B		90M	2025-12
Illumina	USD 564M		26M	2025-12
Mettler Toledo International	USD 387.23M		14.58M	2025-12
Myriad Genetics	USD 30.6M		1000K	2025-12
OraSure Technologies	USD 31.06M		2.34M	2025-12
Pacific Biosciences Of California	USD 49.28M		3.87M	2025-12
Pfizer	USD 11.47B		201M	2025-09
Repligen	USD 170.46M		10.14M	2025-12
Revvity	USD 379.5M		420K	2025-12
Standard Biotools	USD 19.98M		5.44M	2025-12
Thermo Fisher Scientific	USD 5.43B		320M	2025-12
Waters	USD 572.37M		570K	2025-12
West Pharmaceutical Services	USD 443.9M		5.9M	2025-12